SCHEMBL2530003

SCHEMBL2530003

C1CC2C(=C3CCC2CC3)CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29903206 0.68
SCHEMBL28843163 0.67 KDM4E (0.32)
SCHEMBL7111236 0.56
SCHEMBL4187253 0.56
SCHEMBL28994869 0.53 KDM4E (0.33)
Ammonia Solution, Strong SCHEMBL30691854 0.53
Iodide SCHEMBL30691848 0.53
Bromide SCHEMBL9535826 0.53
SCHEMBL15751669 0.53
SCHEMBL13209322 0.53 PNMT (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8232360-B2 Stereoregular ROMP polymers RESEARCH FOUNDATION OF STATE UNIVERSITY OF N.Y. (US) 2012-07-31 US disclosed
US-20110251363-A1 STEREOREGULAR ROMP POLYMERS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2011-10-13 US disclosed
WO-2008019217-A2 STEREOREGULAR ROMP POLYMERS THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2008-02-14 WO disclosed
WO-2005059098-A2 METHODS AND COMPOSITIONS FOR TREATING AND/OR PREVENTING NEURODEGENERATIVE CONDITIONS CREIGHTON UNIVERSITY (US) 2005-06-30 WO disclosed